
Diageo, UP Fintech, Regencell Bioscience, RBB Bancorp, Hf Foods Group, China SXT Pharmaceuticals, and BGM Group are the seven Chinese stocks to watch today, according to MarketBeat’s stock screener tool. Chinese stocks are shares issued by companies that are incorporated in or derive the majority of their revenue from mainland China, Hong Kong, or other Chinese jurisdictions. They include firms listed on mainland exchanges (Shanghai, Shenzhen), the Hong Kong Stock Exchange, and China-related ADRs/ADRs listed abroad. For investors, they offer direct exposure to China’s economy but come with unique considerations such as different accounting and regulatory standards, currency and geopolitical risk, and varying degrees of market transparency. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.
Diageo (DEO)
Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.
UP Fintech (TIGR)
UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.
Read Our Latest Research Report on TIGR
Regencell Bioscience (RGC)
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.
Read Our Latest Research Report on RGC
RBB Bancorp (RBB)
RBB Bancorp operates as the bank holding company for Royal Business Bank that provides various banking products and services to the Chinese-American, Korean-American, and other Asian-American communities. Its deposit products include checking, savings, and money market accounts, as well as certificates of deposit.
Read Our Latest Research Report on RBB
Hf Foods Group (HFFG)
HF Foods Group Inc., through its subsidiaries, markets and distributes Asian specialty food, seafood, fresh produce, frozen and dry food, and non-food products to Asian and Chinese restaurants, and other foodservice customers in the United States. The company offers seafood, including lobsters, shrimp, crabs, scallops, and fish; Asian specialty food items, including noodles, rice, dried mushrooms and beans, sauces and seasonings, and spring rolls, as well as canned products, such as preserved vegetables, bamboo shoots, and water chestnuts; and meat and poultry products, including beef, pork, chicken, and duck.
Read Our Latest Research Report on HFFG
China SXT Pharmaceuticals (SXTC)
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.
Read Our Latest Research Report on SXTC
BGM Group (BGM)
Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.
Read Our Latest Research Report on BGM
Further Reading
- MarketBeat’s Top Five Stocks to Own in February 2026
- Rockwell Automation Stock Dips After Earnings Beat: Why Bulls See a Fast Rebound
- Vertical Aerospace: Commercial Wins, Stock Price Lows
- Bloom Energy Blossoms on Rapidly Accelerating Outlook
- Texas Instruments Executes a $7.5B Deal and an AI Strategy Pivot
- MarketBeat Week in Review – 02/02 – 02/06
